Search results

As resistance to synthetic biology slowly coalesces, governments and scientists need to be proactive to avoid a repetition of the near moratorium on genetically modified crops in Europe.

"In modern global economies, how can we govern science, technology, risk and the environment more effectively? As the pace of innovation has increased, the governance agenda has, itself, been changing; policy-making is in a state of flux and governments are stressing the need for more integrated or "joined up" policies to deal with new orders of complexity. This timely book describes the new approaches to policy for science, technology, risk and the environment in the context of this modern governance agenda. The authors examine the extent to which governance is integrated, where gaps exist and where further integration might be helpful for a range of policy areas. The interdisciplinary approach bridges scientific, technical and socio-economic research at global, European, UK and regional levels. New Modes of Governance will be a valuable resource for academics, policy-makers, regulators, and science and industry communities involved in innovation."--Provided by publisher.

Food security has become a serious issue for governments around the world. Europe stands to have a key role, but the European Union will need to change its policies on plant biotechnology to do so.

Why do corporations develop technologies which can be associated with the generation of various environmental risks and how are the technologies that they develop governed by factors within and around firms? The authors examine the factors that have motivated and guided technological innovation, based on an examination of multinational companies developing genetically modified (GM) crops for the European market. The analysis is based on an inherently interdisciplinary approach to the study of innovation, which incorporates factors that are governed endogenously through the processes within companies (that is, strategic decisionmaking) and exogenously through interactions between firms and their external constituents (that is, government policies and regulations, and stakeholder and public perspectives and engagements). It is found that the introduction of GM technologies in Europe has been shaped significantly by public perception and societal reactions. It is also found that the aspects of industry strategies which contributed most to the course of European public opposition to GM crops were: (a) the choice of first-generation GM products; (b) interactions between pesticide-product and biotechnology-product strategies in different companies, and industry's efforts to present their sector and its products as contributing to sustainable development; (c) cultural and world-view differences between companies; and (d) company responses to European biotechnology policies and risk regulation. It is demonstrated that actions which seem rational to individual actors (corporations, governments, public interest groups) can have counterintuitive, and often counterproductive, outcomes in the longer term and when considered from the perspective of interactions within broader governance processes.